Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs Gel for Difficult Skin Ulcers
NCT02685722Phase 1Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Umbilical cord mesenchymal stem cells (Chinese PLA General Hospital) in skin ulcer (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Frequency of Adverse Events at 6 months. Started Jan 2012; status: completed.
02
Drugs
Umbilical cord mesenchymal stem cells (Chinese PLA General Hospital)
03
Conditions
skin ulcer
Beyond the preview
Go deeper on NCT02685722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685722.